IPP Bureau
Lupin receives USFDA approval for topical solution
By IPP Bureau - March 03, 2022
The product will be manufactured at Lupin’s facility in Pithampur, India
Medix Biochemica announces expansion of its porfolio
By IPP Bureau - March 03, 2022
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
Masina Hospital opens a new dialysis centre
By IPP Bureau - March 03, 2022
The availability of advanced SLED dialysis for critical patients, Plasmapheresis, CRRT machines along with ICCU dialysis complete the centre in every way
Merck KGaA reports higher profits on strong volumes across its businesses
By IPP Bureau - March 03, 2022
Company expects strong organic growth in sales, EBITDA in 2022
Sinocompound announces commercial-scale production of QPhos ligand
By IPP Bureau - March 03, 2022
The phosphine ligand is available on the kilo scale for the first time, providing scientists with a powerful solution for cross-coupling chemistry
DCGI approves Themis Medicare's Viralex for Covid-19 treatment
By IPP Bureau - March 03, 2022
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
USFDA issues new clinical trial guidelines for cancer treatments
By IPP Bureau - March 02, 2022
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
CryptoRelief partners with IIT Madras to establish wastewater-based research centre
By IPP Bureau - March 02, 2022
Scientists worldwide have started employing wastewater analysis as an efficient and cost-effective approach for assessing the dynamics of the virus in a population. Several scientific methods are being developed to rapidly decode the message carried by sewage
Mapmygenome launches Genomics Experience Centre in Bengaluru
By IPP Bureau - March 02, 2022
At the new centre, customers get a real-time experience of the process of genetic testing and actionable plans in preventive healthcare under the expertise of certified genetic counsellors
SeQuent Scientific completes acquisition of Nourrie in Brazil
By IPP Bureau - March 02, 2022
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Dr Julie L. Gerberding to retire from Merck as Chief Patient Officer
By IPP Bureau - March 02, 2022
Earlier today, the Foundation for the National Institutes of Health (FNIH) announced that Dr. Gerberding will become CEO of the FNIH on May 16
Amrita University launches wearable device for home monitoring of glucose and BP
By IPP Bureau - March 02, 2022
Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home
Univar Solutions opens latest Solution Centre for its global ecosystem of innovation
By IPP Bureau - March 02, 2022
State-of-the-art laboratory to support ingredient and specialty chemical innovation, product formulation application development and more sustainable solutions across Europe and beyond
USFDA approves first generic version of Apokyn cartridges
By IPP Bureau - March 02, 2022
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
Amneal enters U.S. biosimilars market with approval of Releukotm
By IPP Bureau - March 02, 2022
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
